TGFB1 and hepatocellular carcinoma: While at later stages, it promoted tumor growth by inducing angiogenesis, immune suppression, and epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma by activating the TGF-β/Smad pathway [19].